MEREO BIOPHARMA GROUP PLC

(MREO)
  Report
Delayed Nasdaq  -  04:00 2022-08-08 pm EDT
1.180 USD   -8.53%
11:08aEuropean ADRs Move Higher in Monday Trading
MT
08/05European ADRs Move Lower in Friday Trading
MT
08/01European ADRs Move Higher in Monday Trading
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

European ADRs Move Lower in Friday Trading

06/17/2022 | 11:09am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ADAPTIMMUNE THERAPEUTICS PLC -5.13% 2.22 Delayed Quote.-37.60%
ARGENX SE -0.06% 360 Real-time Quote.14.24%
AVADEL PHARMACEUTICALS PLC 7.31% 6.31 Delayed Quote.-27.23%
BHP GROUP LIMITED 0.80% 39.12 Delayed Quote.-6.48%
BICYCLE THERAPEUTICS PLC 5.53% 27.65 Delayed Quote.-56.96%
BP PLC 1.25% 416.3 Delayed Quote.24.40%
CELLECTIS S.A. 8.87% 3.56 Real-time Quote.-56.05%
DBV TECHNOLOGIES 3.42% 5.29 Real-time Quote.67.21%
ENI SPA -0.09% 11.446 Delayed Quote.-6.25%
ERYTECH PHARMA S.A. 0.66% 1.218 Real-time Quote.-42.92%
HSBC HOLDINGS PLC 0.66% 545.5 Delayed Quote.20.78%
LONDON BRENT OIL 2.51% 96.21 Delayed Quote.21.13%
MEREO BIOPHARMA GROUP PLC -8.53% 1.18 Delayed Quote.-19.38%
MORPHOSYS AG 0.13% 22.46 Delayed Quote.-32.74%
SHELL PLC 0.53% 2161.5 Delayed Quote.32.57%
TOTALENERGIES SE 1.90% 49.82 Real-time Quote.9.55%
WTI 2.76% 90.405 Delayed Quote.17.49%
ZEALAND PHARMA A/S -1.86% 126.8 Delayed Quote.-10.96%
All news about MEREO BIOPHARMA GROUP PLC
11:08aEuropean ADRs Move Higher in Monday Trading
MT
08/05European ADRs Move Lower in Friday Trading
MT
08/01European ADRs Move Higher in Monday Trading
MT
07/29European ADRs Move Higher in Friday Trading
MT
07/27European ADRs Move Higher in Wednesday Trading
MT
07/25European ADRs Move Higher in Monday Trading
MT
07/21European ADRs Nudge Higher in Thursday Trading
MT
07/20European ADRs Move Lower in Wednesday Trading
MT
07/19European ADRs Rise in Tuesday Trading
MT
07/12European ADRs Move Lower in Tuesday Trading
MT
More news
Analyst Recommendations on MEREO BIOPHARMA GROUP PLC
More recommendations
Financials
Sales 2022 - - -
Net income 2022 -39,7 M -47,8 M -47,8 M
Net cash 2022 32,5 M 39,1 M 39,1 M
P/E ratio 2022 -14,6x
Yield 2022 -
Capitalization 116 M 140 M 140 M
EV / Sales 2022 -
EV / Sales 2023 8,92x
Nbr of Employees 49
Free-Float 51,6%
Chart MEREO BIOPHARMA GROUP PLC
Duration : Period :
Mereo BioPharma Group plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEREO BIOPHARMA GROUP PLC
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 107,10 GBX
Average target price 562,57 GBX
Spread / Average Target 425%
EPS Revisions
Managers and Directors
Denise Vera Scots-Knight Chief Executive Officer & Director
Christine Fox Chief Financial Officer
Michael S. Wyzga Chairman
John A. Lewicki Chief Scientific Officer
Suba Krishnan Senior Vice President-Clinical Development
Sector and Competitors
1st jan.Capi. (M$)
MEREO BIOPHARMA GROUP PLC-19.38%140
GILEAD SCIENCES, INC.-15.87%76 626
VERTEX PHARMACEUTICALS31.16%73 868
REGENERON PHARMACEUTICALS, INC.-2.84%65 600
BIONTECH SE-28.97%44 499
WUXI APPTEC CO., LTD.-20.64%41 093